{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:42:14Z","timestamp":1790710934434,"version":"4.1.0"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1038\/s41433-024-03341-5","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T13:44:01Z","timestamp":1726667041000},"page":"845-859","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hallmarks of aging in age-related macular degeneration and age-related neurological disorders: novel insights into common mechanisms and clinical relevance"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6773-9967","authenticated-orcid":false,"given":"Stela","family":"Vujosevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Limoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1813-0017","authenticated-orcid":false,"given":"Igor","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"3341_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15:565\u201381.","journal-title":"Nat Rev Neurol"},{"key":"3341_CR2","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s43587-022-00318-5","volume":"2","author":"PA Crane","year":"2022","unstructured":"Crane PA, Wilkinson G, Teare H. Healthspan versus lifespan: new medicines to close the gap. Nat Aging. 2022;2:984\u20138.","journal-title":"Nat Aging"},{"key":"3341_CR3","doi-asserted-by":"crossref","unstructured":"Knopman DS, Amieva H, Petersen RC, Ch\u00e9telat G, Holtzman DM, Hyman BT, et al. Alzheimer disease. Nat Rev Dis Primers. 2021 Dec 1;7.","DOI":"10.1038\/s41572-021-00269-y"},{"key":"3341_CR4","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet 2021;397:2284\u2013303.","journal-title":"Lancet"},{"key":"3341_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jama.2023.26074","volume":"331","author":"M Fleckenstein","year":"2024","unstructured":"Fleckenstein M, Schmitz-Valckenberg S, Chakravarthy U. Age-related macular degeneration: a review. JAMA 2024;331:147\u201357.","journal-title":"JAMA"},{"key":"3341_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell 2023;186:243\u201378.","journal-title":"Cell"},{"key":"3341_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune\u2013metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576\u201390.","journal-title":"Nat Rev Endocrinol"},{"key":"3341_CR8","unstructured":"CHMP. Syfovre, INN-pegcetacoplan. [cited 2024 Feb 28]; Available from: https:\/\/investors.apellis.com\/news-releases\/news-release-details\/fda-approves-syfovretm-pegcetacoplan-injection-first-and-only."},{"key":"3341_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"JD Steinmetz","year":"2024","unstructured":"Steinmetz JD, Seeher KM, Schiess N, Nichols E, Cao B, Servili C, et al. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 2024;23:344\u201381.","journal-title":"Lancet Neurol"},{"key":"3341_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/1745017901309010088","volume":"9","author":"RT Vieira","year":"2013","unstructured":"Vieira RT, Caixeta L, Machado S, Silva AC, Nardi AE, Arias-Carri\u00f3n O, Carta MG. Epidemiology of early-onset dementia: a review of the literature. Clin Pr Epidemiol Ment Health. 2013;9:88\u201395.","journal-title":"Clin Pr Epidemiol Ment Health"},{"key":"3341_CR11","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A. Epidemiology of Parkinson\u2019s disease. J Neural Transm (Vienna). 2017;124:901\u20135.","journal-title":"J Neural Transm (Vienna)"},{"key":"3341_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1017\/S0033291713000494","volume":"44","author":"SA Vann Jones","year":"2014","unstructured":"Vann Jones SA, O\u2019Brien JT. The prevalence and incidence of dementia with lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2014;44:673\u201383.","journal-title":"Psychol Med"},{"key":"3341_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jalz.2017.07.755","volume":"14","author":"MR Azarpazhooh","year":"2018","unstructured":"Azarpazhooh MR, Avan A, Cipriano LE, Munoz DG, Sposato LA, Hachinski V. Concomitant vascular and neurodegenerative pathologies double the risk of dementia. Alzheimers Dement. 2018;14:148\u201356.","journal-title":"Alzheimers Dement"},{"key":"3341_CR14","doi-asserted-by":"publisher","first-page":"100938","DOI":"10.1016\/j.preteyeres.2020.100938","volume":"83","author":"AH Kashani","year":"2021","unstructured":"Kashani AH, Asanad S, Chan JW, Singer MB, Zhang J, Sharifi M, et al. Past, present and future role of retinal imaging in neurodegenerative disease. Prog Retin Eye Res. 2021;83:100938.","journal-title":"Prog Retin Eye Res"},{"key":"3341_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/jamaophthalmol.2022.4845","volume":"141","author":"E Costanzo","year":"2023","unstructured":"Costanzo E, Lengyel I, Parravano M, Biagini I, Veldsman M, Badhwar A, et al. Ocular biomarkers for Alzheimer disease dementia: an umbrella review of systematic reviews and Meta-analyses. JAMA Ophthalmol. 2023;141:84\u201391.","journal-title":"JAMA Ophthalmol"},{"key":"3341_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/tvst.12.1.13","volume":"12","author":"E Pead","year":"2023","unstructured":"Pead E, Thompson AC, Grewal DS, McGrory S, Robbins CB, Ma JP, et al. Retinal vascular changes in Alzheimer\u2019s dementia and mild cognitive impairment: a pilot study using ultra-widefield imaging. Transl Vis Sci Technol. 2023;12:13\u201313.","journal-title":"Transl Vis Sci Technol"},{"key":"3341_CR17","doi-asserted-by":"crossref","unstructured":"Hadoux X, Hui F, Lim JKH, Masters CL, P\u00e9bay A, Chevalier S, et al. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer\u2019s disease. Nat Commun. 2019;10.","DOI":"10.1038\/s41467-019-12242-1"},{"key":"3341_CR18","doi-asserted-by":"crossref","unstructured":"Wagner SK, Fu DJ, Faes L, Liu X, Huemer J, Khalid H, et al. Insights into systemic disease through retinal imaging-based oculomics. Transl Vis Sci Technol. 2020;9.","DOI":"10.1167\/tvst.9.2.6"},{"key":"3341_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41586-023-06555-x","volume":"622","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Chia MA, Wagner SK, Ayhan MS, Williamson DJ, Struyven RR, et al. A foundation model for generalizable disease detection from retinal images. Nature 2023;622:156\u201363.","journal-title":"Nature"},{"key":"3341_CR20","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1038\/s41433-023-02481-4","volume":"37","author":"Y Xu","year":"2023","unstructured":"Xu Y, Phu J, Aung HL, Hesam-Shariati N, Keay L, Tully PJ, et al. Frequency of coexistent eye diseases and cognitive impairment or dementia: a systematic review and meta-analysis. Eye (Lond). 2023;37:3128\u201336.","journal-title":"Eye (Lond)"},{"key":"3341_CR21","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3233\/JAD-210250","volume":"83","author":"E Ku\u017ama","year":"2021","unstructured":"Ku\u017ama E, Littlejohns TJ, Khawaja AP, Llewellyn DJ, Ukoumunne OC, Thiem U. Visual impairment, eye diseases, and dementia risk: a systematic review and meta-analysis. J Alzheimers Dis. 2021;83:1073\u201387.","journal-title":"J Alzheimers Dis"},{"key":"3341_CR22","first-page":"1777","volume":"103","author":"SS Rong","year":"2019","unstructured":"Rong SS, Lee BY, Kuk AK, Yu XT, Li SS, Li J, et al. Comorbidity of dementia and age-related macular degeneration calls for clinical awareness: a meta-analysis. Br J Ophthalmol. 2019;103:1777\u201383.","journal-title":"Br J Ophthalmol"},{"key":"3341_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ajo.2022.11.005","volume":"247","author":"HR Tsai","year":"2023","unstructured":"Tsai HR, Lo RY, Liang KH, Chen TL, Huang HK, Wang JH, et al. Risk of subsequent dementia or Alzheimer disease among patients with age-related macular degeneration: a systematic review and meta-analysis. Am J Ophthalmol. 2023;247:161\u20139.","journal-title":"Am J Ophthalmol"},{"key":"3341_CR24","first-page":"1","volume":"0","author":"S Song Rong","year":"2019","unstructured":"Song Rong S, Yee Lee B, Kuk AK, Ting Yu X, Li SS, Li J, et al. Comorbidity of dementia and age-related macular degeneration calls for clinical awareness: a meta-analysis. Br J Ophthalmol. 2019;0:1\u20137.","journal-title":"Br J Ophthalmol"},{"key":"3341_CR25","doi-asserted-by":"crossref","unstructured":"Chung SD, Ho JD, Hu CC, Lin HC, Sheu JJ Increased risk of Parkinson disease following a diagnosis of neovascular age-related macular degeneration: a retrospective cohort study. Am J Ophthalmol. 2014;157.","DOI":"10.1016\/j.ajo.2013.09.026"},{"key":"3341_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ajo.2019.11.001","volume":"210","author":"S Choi","year":"2020","unstructured":"Choi S, Jahng WJ, Park SM, Jee D. Association of age-related macular degeneration on Alzheimer or Parkinson disease: a retrospective cohort study. Am J Ophthalmol. 2020;210:41\u20137.","journal-title":"Am J Ophthalmol"},{"key":"3341_CR27","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1111\/ene.15896","volume":"30","author":"JM Yoon","year":"2023","unstructured":"Yoon JM, Lim DH, Youn J, Han K, Kim BS, Jung W, et al. Increased risk of Parkinson\u2019s disease amongst patients with age-related macular degeneration and visual disability: A nationwide cohort study. Eur J Neurol. 2023;30:2641\u20139.","journal-title":"Eur J Neurol"},{"key":"3341_CR28","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3233\/JPD-213143","volume":"12","author":"M Pengo","year":"2022","unstructured":"Pengo M, Murueta-Goyena A, Teijeira-Portas S, Acera M, Del Pino R, S\u00e1ez-Atxukarro O, et al. Impact of visual impairment on vision-related quality of life in Parkinson\u2019s disease. J Parkinsons Dis. 2022;12:1633\u201343.","journal-title":"J Parkinsons Dis"},{"key":"3341_CR29","doi-asserted-by":"crossref","unstructured":"Raphael BA, Galetta KM, Jacobs DA, Markowitz CE, Liu GT, Nano-Schiavi ML, et al. Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25. Am J Ophthalmol. 2006;142.","DOI":"10.1016\/j.ajo.2006.06.060"},{"key":"3341_CR30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ophtha.2011.06.040","volume":"119","author":"Z Almer","year":"2012","unstructured":"Almer Z, Klein KS, Marsh L, Gerstenhaber M, Repka MX. Ocular motor and sensory function in Parkinson\u2019s disease. Ophthalmology 2012;119:178\u201382.","journal-title":"Ophthalmology"},{"key":"3341_CR31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54:412\u201336.","journal-title":"Nat Genet"},{"key":"3341_CR32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Nalls MA, Singleton AB. The genetic architecture of Parkinson\u2019s disease. Lancet Neurol. 2020;19:170\u20138.","journal-title":"Lancet Neurol"},{"key":"3341_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","volume":"48","author":"LG Fritsche","year":"2016","unstructured":"Fritsche LG, Igl W, Bailey JNC, Grassmann F, Sengupta S, Bragg-Gresham JL, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48:134\u201343.","journal-title":"Nat Genet"},{"key":"3341_CR34","doi-asserted-by":"crossref","unstructured":"Acar IE, Galesloot TE, Luhmann UFO, Fauser S, Gay\u00e1n J, den Hollander AI, et al. Whole Genome Sequencing Identifies Novel Common and Low-Frequency Variants Associated With Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2023;64.","DOI":"10.1167\/iovs.64.14.24"},{"key":"3341_CR35","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1007\/s12035-020-02024-y","volume":"57","author":"H Tan","year":"2020","unstructured":"Tan H, Lv M, Tan X, Su G, Chang R, Yang P. Sharing of genetic association signals by age-related macular degeneration and Alzheimer\u2019s Disease at multiple levels. Mol Neurobiol. 2020;57:4488\u201399.","journal-title":"Mol Neurobiol"},{"key":"3341_CR36","doi-asserted-by":"publisher","first-page":"100952","DOI":"10.1016\/j.preteyeres.2021.100952","volume":"84","author":"S De Jong","year":"2021","unstructured":"De Jong S, Gagliardi G, Garanto A, De Breuk A, Lechanteur YTE, Katti S, et al. Implications of genetic variation in the complement system in age-related macular degeneration. Prog Retin Eye Res. 2021;84:100952.","journal-title":"Prog Retin Eye Res"},{"key":"3341_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.preteyeres.2017.09.001","volume":"62","author":"CB Toomey","year":"2018","unstructured":"Toomey CB, Johnson LV, Bowes Rickman C. Complement factor H in AMD: Bridging genetic associations and pathobiology. Prog Retin Eye Res. 2018;62:38\u201357.","journal-title":"Prog Retin Eye Res"},{"key":"3341_CR38","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/npp.2015.232","volume":"41","author":"DF Zhang","year":"2016","unstructured":"Zhang DF, Li J, Wu H, Cui Y, Bi R, Zhou HJ, et al. CFH variants affect structural and functional brain changes and genetic risk of Alzheimer\u2019s disease. Neuropsychopharmacology 2016;41:1034\u201345.","journal-title":"Neuropsychopharmacology"},{"key":"3341_CR39","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/ajmg.b.30668","volume":"147B","author":"M Zetterberg","year":"2008","unstructured":"Zetterberg M, Landgren S, Andersson ME, Palm\u00e9r MS, Gustafson DR, Skoog I, et al. Association of complement factor H Y402H gene polymorphism with Alzheimer\u2019s disease. Am J Med Genet Part B: Neuropsychiatr Genet. 2008;147B:720\u20136.","journal-title":"Am J Med Genet Part B: Neuropsychiatr Genet"},{"key":"3341_CR40","doi-asserted-by":"crossref","unstructured":"Veteleanu A, Stevenson-Hoare J, Keat S, Daskoulidou N, Zetterberg H, Heslegrave A, et al. Alzheimer\u2019s disease-associated complement gene variants influence plasma complement protein levels. J Neuroinflammation. 2023;20.","DOI":"10.1186\/s12974-023-02850-6"},{"key":"3341_CR41","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","volume":"101","author":"ME Belloy","year":"2019","unstructured":"Belloy ME, Napolioni V, Greicius MD. A quarter century of APOE and Alzheimer\u2019s disease: progress to date and the path forward. Neuron 2019;101:820\u201338.","journal-title":"Neuron"},{"key":"3341_CR42","doi-asserted-by":"crossref","unstructured":"Chernyaeva L, Ratti G, Teiril\u00e4 L, Fudo S, Rankka U, Pelkonen A, et al. Reduced binding of apoE4 to complement factor H promotes amyloid-\u03b2 oligomerization and neuroinflammation. EMBO Rep. 2023;24.","DOI":"10.15252\/embr.202256467"},{"key":"3341_CR43","first-page":"9497147","volume":"2018","author":"S Pang","year":"2018","unstructured":"Pang S, Li J, Zhang Y, Chen J. Meta-analysis of the relationship between the APOE gene and the onset of Parkinson\u2019s disease dementia. Parkinsons Dis. 2018;2018:9497147.","journal-title":"Parkinsons Dis"},{"key":"3341_CR44","first-page":"1311","volume":"14","author":"M Abyadeh","year":"2023","unstructured":"Abyadeh M, Gupta V, Paulo JA, Sheriff S, Shadfar S, Fitzhenry M, et al. Apolipoprotein \u03b5 in brain and retinal neurodegenerative diseases. Aging Dis. 2023;14:1311\u201330.","journal-title":"Aging Dis"},{"key":"3341_CR45","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/14728222.2023.2235718","volume":"27","author":"T Paseban","year":"2023","unstructured":"Paseban T, Alavi MS, Etemad L, Roohbakhsh A. The role of the ATP-binding cassette A1 (ABCA1) in neurological disorders: a mechanistic review. Expert Opin Ther Targets. 2023;27:531\u201352.","journal-title":"Expert Opin Ther Targets"},{"key":"3341_CR46","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0002-9394(00)00552-3","volume":"130","author":"K Kimura","year":"2000","unstructured":"Kimura K, Isashiki Y, Sonoda S, Kakiuchi-Matsumoto T, Ohba N. Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol. 2000;130:769\u201373.","journal-title":"Am J Ophthalmol"},{"key":"3341_CR47","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1601-183X.2007.00308.x","volume":"6","author":"HW Wiener","year":"2007","unstructured":"Wiener HW, Perry RT, Chen Z, Harrell LE, Go RCP. A polymorphism in SOD2 is associated with development of Alzheimer\u2019s disease. Genes Brain Behav. 2007;6:770\u20136.","journal-title":"Genes Brain Behav"},{"key":"3341_CR48","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.clinbiochem.2010.05.009","volume":"43","author":"V Wang","year":"2010","unstructured":"Wang V, Chen SY, Chuang TC, Shan DE, Soong BW, Kao MC. Val-9Ala and Ile+58Thr polymorphism of MnSOD in Parkinson\u2019s disease. Clin Biochem. 2010;43:979\u201382.","journal-title":"Clin Biochem"},{"key":"3341_CR49","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s11033-011-0955-3","volume":"39","author":"E Synowiec","year":"2012","unstructured":"Synowiec E, Szaflik J, Chmielewska M, Wozniak K, Sklodowska A, Waszczyk M, et al. An association between polymorphism of the heme oxygenase-1 and -2 genes and age-related macular degeneration. Mol Biol Rep. 2012;39:2081\u20137.","journal-title":"Mol Biol Rep"},{"key":"3341_CR50","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1007\/s10072-021-05830-x","volume":"43","author":"R Xiong","year":"2022","unstructured":"Xiong R, Zhang B. Association of HMOX-1 rs2071747 with sporadic Parkinson\u2019s disease in southern Han Chinese. Neurol Sci. 2022;43:3671\u20135.","journal-title":"Neurol Sci"},{"key":"3341_CR51","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/FPC.0b013e328348f729","volume":"21","author":"P Ayuso","year":"2011","unstructured":"Ayuso P, Mart\u00ednez C, Lorenzo-Betancor O, Pastor P, Luengo A, Jim\u00e9nez-Jim\u00e9nez FJ, et al. A polymorphism located at an ATG transcription start site of the heme oxygenase-2 gene is associated with classical Parkinson\u2019s disease. Pharmacogenet Genomics. 2011;21:565\u201371.","journal-title":"Pharmacogenet Genomics"},{"key":"3341_CR52","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1126\/science.1112766","volume":"309","author":"H Kurosu","year":"2005","unstructured":"Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, et al. Suppression of aging in mice by the hormone Klotho. Science 2005;309:1829\u201333.","journal-title":"Science"},{"key":"3341_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-023-05851-8","volume":"14","author":"HY Jang","year":"2023","unstructured":"Jang HY, Kim SJ, Park KS, Kim JH. Klotho prevents transforming growth factor-\u03b22-induced senescent-like morphological changes in the retinal pigment epithelium. Cell Death Dis. 2023;14:1\u201311. 2023 14:5","journal-title":"Cell Death Dis"},{"key":"3341_CR54","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/jamaneurol.2020.0414","volume":"77","author":"ME Belloy","year":"2020","unstructured":"Belloy ME, Napolioni V, Han SS, Le Guen Y, Greicius MD. Association of Klotho-VS heterozygosity with risk of Alzheimer disease in individuals who carry APOE4. JAMA Neurol. 2020;77:849\u201362.","journal-title":"JAMA Neurol"},{"key":"3341_CR55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12031-019-01345-5","volume":"69","author":"M Sedighi","year":"2019","unstructured":"Sedighi M, Baluchnejadmojarad T, Fallah S, Moradi N, Afshin-Majdd S, Roghani M. Klotho ameliorates cellular inflammation via suppression of cytokine release and upregulation of miR-29a in the PBMCs of diagnosed Alzheimer\u2019s disease patients. J Mol Neurosci. 2019;69:157\u201365.","journal-title":"J Mol Neurosci"},{"key":"3341_CR56","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.exger.2017.10.023","volume":"100","author":"T Baluchnejadmojarad","year":"2017","unstructured":"Baluchnejadmojarad T, Eftekhari SM, Jamali-Raeufy N, Haghani S, Zeinali H, Roghani M. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson\u2019s disease: involvement of PKA\/CaMKII\/CREB signaling. Exp Gerontol. 2017;100:70\u20136.","journal-title":"Exp Gerontol"},{"key":"3341_CR57","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.ophtha.2020.11.024","volume":"128","author":"JM Colijn","year":"2021","unstructured":"Colijn JM, Meester-Smoor M, Verzijden T, de Breuk A, Silva R, Merle BMJ, et al. Genetic risk, lifestyle, and age-related macular degeneration in Europe: the EYE-RISK consortium. Ophthalmology 2021;128:1039\u201349.","journal-title":"Ophthalmology"},{"key":"3341_CR58","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 2016;15:1257\u201372.","journal-title":"Lancet Neurol"},{"key":"3341_CR59","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.2013.4997","volume":"309","author":"EY Chew","year":"2013","unstructured":"Chew EY, Clemons TE, SanGiovanni JP, Danis R, Ferris FL, Elman M, et al. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013;309:2005\u201315.","journal-title":"JAMA"},{"key":"3341_CR60","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Romera MC, Silva-Viguera MC, L\u00f3pez-Izquierdo I, L\u00f3pez-Mu\u00f1oz A, Capote-Puente R, Gargallo-Mart\u00ednez B Effect of macular pigment carotenoids on cognitive functions: A systematic review. Physiol Behav. 2022;254.","DOI":"10.1016\/j.physbeh.2022.113891"},{"key":"3341_CR61","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3233\/JAD-220556","volume":"90","author":"JM Nolan","year":"2022","unstructured":"Nolan JM, Power R, Howard AN, Bergin P, Roche W, Prado-Cabrero A, et al. Supplementation with carotenoids, omega-3 fatty acids, and vitamin E has a positive effect on the symptoms and progression of Alzheimer\u2019s disease. J Alzheimers Dis. 2022;90:233\u201349.","journal-title":"J Alzheimers Dis"},{"key":"3341_CR62","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.4103\/1673-5374.389745","volume":"19","author":"M Zhang","year":"2024","unstructured":"Zhang M, Liang C, Chen X, Cai Y, Cui L. Interplay between microglia and environmental risk factors in Alzheimer\u2019s disease. Neural Regen Res. 2024;19:1718\u201327.","journal-title":"Neural Regen Res"},{"key":"3341_CR63","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jamaneurol.2021.3926","volume":"78","author":"SY Yoon","year":"2021","unstructured":"Yoon SY, Suh JH, Yang SN, Han K, Kim YW. Association of physical activity, including amount and maintenance, with all-cause mortality in Parkinson disease. JAMA Neurol. 2021;78:1446\u201353.","journal-title":"JAMA Neurol"},{"key":"3341_CR64","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41433-021-01780-y","volume":"36","author":"JB Lin","year":"2022","unstructured":"Lin JB, Halawa OA, Husain D, Miller JW, Vavvas DG. Dyslipidemia in age-related macular degeneration. Eye (Lond). 2022;36:312\u20138.","journal-title":"Eye (Lond)"},{"key":"3341_CR65","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1001\/jamaophthalmol.2023.6014","volume":"142","author":"S Scott Sutton","year":"2024","unstructured":"Scott Sutton S, Magagnoli JMS, Cummings TH, Hardin JW, Ambati J. Alzheimer disease treatment with acetylcholinesterase inhibitors and incident age-related macular degeneration. JAMA Ophthalmol. 2024;142:108\u201314.","journal-title":"JAMA Ophthalmol"},{"key":"3341_CR66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41582-021-00577-7","volume":"18","author":"M Nassan","year":"2022","unstructured":"Nassan M, Videnovic A. Circadian rhythms in neurodegenerative disorders. Nat Rev Neurol. 2022;18:7\u201324.","journal-title":"Nat Rev Neurol"},{"key":"3341_CR67","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.aav2546","volume":"363","author":"JK Holth","year":"2019","unstructured":"Holth JK, Fritschi SK, Wang C, Pedersen NP, Cirrito JR, Mahan TE, et al. The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science 2019;363:80\u2013884.","journal-title":"Science"},{"key":"3341_CR68","doi-asserted-by":"publisher","first-page":"101119","DOI":"10.1016\/j.preteyeres.2022.101119","volume":"94","author":"JD Bhoi","year":"2023","unstructured":"Bhoi JD, Goel M, Ribelayga CP, Mangel SC. Circadian clock organization in the retina: From clock components to rod and cone pathways and visual function. Prog Retin Eye Res. 2023;94:101119.","journal-title":"Prog Retin Eye Res"},{"key":"3341_CR69","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41583-023-00788-5","volume":"25","author":"HL Mahoney","year":"2024","unstructured":"Mahoney HL, Schmidt TM. The cognitive impact of light: illuminating ipRGC circuit mechanisms. Nat Rev Neurosci. 2024;25:159\u201375.","journal-title":"Nat Rev Neurosci"},{"key":"3341_CR70","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1177\/11206721221106149","volume":"32","author":"M Parravano","year":"2022","unstructured":"Parravano M, Eandi CM, Figus M, Lupidi M, Menchini F, Nicolo M, et al. Effects of circadian rhythm disruption on retinal physiopathology: considerations from a consensus of experts. Eur J Ophthalmol. 2022;32:2489\u201393.","journal-title":"Eur J Ophthalmol"},{"key":"3341_CR71","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1126\/science.adg5277","volume":"380","author":"KM Zielinska-Dabkowska","year":"2023","unstructured":"Zielinska-Dabkowska KM, Schernhammer ES, Hanifin JP, Brainard GC. Reducing nighttime light exposure in the urban environment to benefit human health and society. Science 2023;380:1130\u20135.","journal-title":"Science"},{"key":"3341_CR72","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1001\/jamaneurol.2023.5491","volume":"81","author":"K Dhana","year":"2024","unstructured":"Dhana K, Agarwal P, James BD, Leurgans SE, Rajan KB, Aggarwal NT, et al. Healthy lifestyle and cognition in older adults with common neuropathologies of dementia. JAMA Neurol. 2024;81:233\u20139.","journal-title":"JAMA Neurol"},{"key":"3341_CR73","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","volume":"13","author":"S Norton","year":"2014","unstructured":"Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer\u2019s disease: an analysis of population-based data. Lancet Neurol. 2014;13:788\u201394.","journal-title":"Lancet Neurol"},{"key":"3341_CR74","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41580-020-00326-6","volume":"22","author":"S Alberti","year":"2021","unstructured":"Alberti S, Hyman AA. Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing. Nat Rev Mol Cell Biol. 2021;22:196\u2013213.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3341_CR75","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.preteyeres.2011.02.004","volume":"30","author":"K Ohno-Matsui","year":"2011","unstructured":"Ohno-Matsui K. Parallel findings in age-related macular degeneration and Alzheimer\u2019s disease. Prog Retin Eye Res. 2011;30:217\u201338.","journal-title":"Prog Retin Eye Res"},{"key":"3341_CR76","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/eye.2015.100","volume":"29","author":"JA Ratnayaka","year":"2015","unstructured":"Ratnayaka JA, Serpell LC, Lotery AJ. Dementia of the eye: the role of amyloid beta in retinal degeneration. Eye (Lond). 2015;29:1013\u201326.","journal-title":"Eye (Lond)"},{"key":"3341_CR77","doi-asserted-by":"publisher","first-page":"11830","DOI":"10.1073\/pnas.192203399","volume":"99","author":"LV Johnson","year":"2002","unstructured":"Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. The Alzheimer\u2019s A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci USA. 2002;99:11830\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3341_CR78","doi-asserted-by":"crossref","unstructured":"Lashkari K, Teague G, Chen H, Lin YQ, Kumar S, McLaughlin MM, et al. A monoclonal antibody targeting amyloid \u03b2 (A\u03b2) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer\u2019s disease. PLoS One. 2018;13.","DOI":"10.1371\/journal.pone.0195751"},{"key":"3341_CR79","doi-asserted-by":"publisher","first-page":"100936","DOI":"10.1016\/j.preteyeres.2020.100936","volume":"83","author":"BJ Kim","year":"2021","unstructured":"Kim BJ, Mastellos DC, Li Y, Dunaief JL, Lambris JD. Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions. Prog Retin Eye Res. 2021;83:100936.","journal-title":"Prog Retin Eye Res"},{"key":"3341_CR80","doi-asserted-by":"crossref","unstructured":"Deng L, Pushpitha K, Joseph C, Gupta V, Rajput R, Chitranshi N, et al. Amyloid \u03b2 induces early changes in the ribosomal machinery, cytoskeletal organization and oxidative phosphorylation in retinal photoreceptor cells. Front Mol Neurosci. 2019;12.","DOI":"10.3389\/fnmol.2019.00024"},{"key":"3341_CR81","doi-asserted-by":"publisher","first-page":"101735","DOI":"10.1016\/j.arr.2022.101735","volume":"81","author":"J Blasiak","year":"2022","unstructured":"Blasiak J, Sobczuk P, Pawlowska E, Kaarniranta K. Interplay between aging and other factors of the pathogenesis of age-related macular degeneration. Ageing Res Rev. 2022;81:101735.","journal-title":"Ageing Res Rev"},{"key":"3341_CR82","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0197-4580(03)00111-8","volume":"25","author":"SP Yang","year":"2004","unstructured":"Yang SP, Bae DG, Kang HJ, Gwag BJ, Gho YS, Chae CB. Co-accumulation of vascular endothelial growth factor with \u03b2-amyloid in the brain of patients with Alzheimer\u2019s disease. Neurobiol Aging. 2004;25:283\u201390.","journal-title":"Neurobiol Aging"},{"key":"3341_CR83","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00702-009-0226-9","volume":"116","author":"BS Desai","year":"2009","unstructured":"Desai BS, Schneider JA, Li JL, Carvey PM, Hendey B. Evidence of angiogenic vessels in Alzheimer\u2019s disease. J Neural Transm. 2009;116:587\u201397.","journal-title":"J Neural Transm"},{"key":"3341_CR84","doi-asserted-by":"publisher","first-page":"e0236283","DOI":"10.1371\/journal.pone.0236283","volume":"15","author":"K Lashkari","year":"2020","unstructured":"Lashkari K, Teague GC, Beattie U, Betts J, Kumar S, McLaughlin MM, et al. Plasma biomarkers of the amyloid pathway are associated with geographic atrophy secondary to age-related macular degeneration. PLoS One. 2020;15:e0236283.","journal-title":"PLoS One"},{"key":"3341_CR85","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/bjophthalmol-2020-318452","volume":"106","author":"TA Cabral De Guimaraes","year":"2022","unstructured":"Cabral De Guimaraes TA, Daich Varela M, Georgiou M, Michaelides M. Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions. Br J Ophthalmol. 2022;106:297\u2013304.","journal-title":"Br J Ophthalmol"},{"key":"3341_CR86","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.oret.2018.03.001","volume":"2","author":"PJ Rosenfeld","year":"2018","unstructured":"Rosenfeld PJ, Berger B, Reichel E, Danis RP, Gress A, Ye L. et al.A randomized phase 2 study of an anti-amyloid \u03b2 monoclonal antibody in geographic atrophy secondary to age-related macular degeneration. Ophthalmol Retina. 2018;2:1028\u201340.","journal-title":"Ophthalmol Retina"},{"key":"3341_CR87","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1126\/science.aac8469","volume":"350","author":"PW O\u2019Toole","year":"2015","unstructured":"O\u2019Toole PW, Jeffery IB. Gut microbiota and aging. Science 2015;350:1214\u20135.","journal-title":"Science"},{"key":"3341_CR88","doi-asserted-by":"crossref","unstructured":"Zhou R, Qian S, Cho WCS, Zhou J, Jin C, Zhong Y, et al. Microbiota-microglia connections in age-related cognition decline. Aging Cell. 2022;21.","DOI":"10.1111\/acel.13599"},{"key":"3341_CR89","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","volume":"49","author":"A Cattaneo","year":"2017","unstructured":"Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49:60\u20138.","journal-title":"Neurobiol Aging"},{"key":"3341_CR90","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/d41586-021-00260-3","volume":"590","author":"C Willyard","year":"2021","unstructured":"Willyard C. How gut microbes could drive brain disorders. Nature 2021;590:22\u20135.","journal-title":"Nature"},{"key":"3341_CR91","doi-asserted-by":"crossref","unstructured":"Mao D, Tao B, Sheng S, Jin H, Chen W, Gao H, et al. Causal effects of gut microbiota on age-related macular degeneration: a mendelian randomization study. Invest Ophthalmol Vis Sci. 2023;64.","DOI":"10.1167\/iovs.64.12.32"},{"key":"3341_CR92","doi-asserted-by":"crossref","unstructured":"Zysset-Burri DC, Morandi S, Herzog EL, Berger LE, Zinkernagel MS The role of the gut microbiome in eye diseases. Prog Retin Eye Res. 2023;92.","DOI":"10.1016\/j.preteyeres.2022.101117"},{"key":"3341_CR93","doi-asserted-by":"crossref","unstructured":"Zysset-Burri DC, Keller I, Berger LE, Largiad\u00e8r CR, Wittwer M, Wolf S, et al. Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration. NPJ Genom Med. 2020;5.","DOI":"10.1038\/s41525-020-00141-0"},{"key":"3341_CR94","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3233\/JAD-180176","volume":"63","author":"ZQ Zhuang","year":"2018","unstructured":"Zhuang ZQ, Shen LL, Li WW, Fu X, Zeng F, Gui L, et al. Gut microbiota is altered in patients with Alzheimer\u2019s disease. J Alzheimers Dis. 2018;63:1337\u201346.","journal-title":"J Alzheimers Dis"},{"key":"3341_CR95","doi-asserted-by":"crossref","unstructured":"Seo DO, O\u2019Donnell D, Jain N, Ulrich JD, Herz J, Li Y, et al. ApoE isoform- and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy. Science. 2023;379.","DOI":"10.1126\/science.add1236"},{"key":"3341_CR96","doi-asserted-by":"crossref","unstructured":"Arjunan P, Swaminathan R, Yuan J, Al-Shabrawey M, Espinosa-Heidmann DG, Nussbaum J, et al. Invasion of human retinal pigment epithelial cells by porphyromonas gingivalis leading to vacuolar\/cytosolic localization and autophagy dysfunction in-vitro. Sci Rep. 2020;10.","DOI":"10.1038\/s41598-020-64449-8"},{"key":"3341_CR97","doi-asserted-by":"crossref","unstructured":"Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, et al. Porphyromonas gingivalis in Alzheimer\u2019s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019;5.","DOI":"10.1126\/sciadv.aau3333"},{"key":"3341_CR98","first-page":"476","volume":"18","author":"AH Tan","year":"2022","unstructured":"Tan AH, Lim SY, Lang AE. The microbiome\u2013gut\u2013brain axis in Parkinson disease \u2014 from basic research to the clinic. Nature Reviews. Neurology. 2022;18:476\u201395.","journal-title":"Neurology"},{"key":"3341_CR99","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","volume":"69","author":"MS Kim","year":"2020","unstructured":"Kim MS, Kim Y, Choi H, Kim W, Park S, Lee D, et al. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model. Gut 2020;69:283\u201394.","journal-title":"Gut"},{"key":"3341_CR100","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/15548627.2022.2069437","volume":"19","author":"K Kaarniranta","year":"2023","unstructured":"Kaarniranta K, Blasiak J, Liton P, Boulton M, Klionsky DJ, Sinha D. Autophagy in age-related macular degeneration. Autophagy 2023;19:388\u2013400.","journal-title":"Autophagy"},{"key":"3341_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/genes11111318","volume":"11","author":"JJ Paterno","year":"2020","unstructured":"Paterno JJ, Koskela A, Hyttinen JMT, Vattulainen E, Synowiec E, Tuuminen R, et al. Autophagy genes for wet age-related macular degeneration in a Finnish case-control study. Genes (Basel). 2020;11:1\u201314.","journal-title":"Genes (Basel)"},{"key":"3341_CR102","doi-asserted-by":"publisher","first-page":"101205","DOI":"10.1016\/j.preteyeres.2023.101205","volume":"96","author":"JI Jim\u00e9nez-Loygorri","year":"2023","unstructured":"Jim\u00e9nez-Loygorri JI, Ben\u00edtez-Fern\u00e1ndez R, Viedma-Poyatos \u00c1, Zapata-Mu\u00f1oz J, Villarejo-Zori B, G\u00f3mez-Sintes R, et al. Mitophagy in the retina: viewing mitochondrial homeostasis through a new lens. Prog Retin Eye Res. 2023;96:101205.","journal-title":"Prog Retin Eye Res"},{"key":"3341_CR103","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41583-022-00588-3","volume":"23","author":"CJ Griffey","year":"2022","unstructured":"Griffey CJ, Yamamoto A. Macroautophagy in CNS health and disease. Nat Rev Neurosci. 2022;23:411\u201327.","journal-title":"Nat Rev Neurosci"},{"key":"3341_CR104","doi-asserted-by":"publisher","first-page":"10866","DOI":"10.18632\/aging.202974","volume":"13","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Presswalla F, Ali RR, Zacks DN, Thompson DA, Miller JML. Pharmacologic activation of autophagy without direct mTOR inhibition as a therapeutic strategy for treating dry macular degeneration. Aging 2021;13:10866\u201390.","journal-title":"Aging"},{"key":"3341_CR105","doi-asserted-by":"crossref","unstructured":"Minturn RJ, Bracha P, Klein MJ, Chhablani J, Harless AM, Maturi RK Intravitreal sirolimus for persistent, exudative age-related macular degeneration: a Pilot Study. Int J Retina Vitreous. 2021;7.","DOI":"10.1186\/s40942-021-00281-0"},{"key":"3341_CR106","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1167\/iovs.13-11650","volume":"54","author":"WT Wong","year":"2013","unstructured":"Wong WT, Dresner S, Forooghian F, Glaser T, Doss L, Zhou M, et al. Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I\/II clinical trial. Invest Ophthalmol Vis Sci. 2013;54:2941.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3341_CR107","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s11357-020-00274-1","volume":"43","author":"R Selvarani","year":"2020","unstructured":"Selvarani R, Mohammed S, Richardson A. Effect of rapamycin on aging and age-related diseases\u2014past and future. GeroScience. 2020;43:1135\u201358. 2020 43:3","journal-title":"GeroScience"},{"key":"3341_CR108","doi-asserted-by":"crossref","unstructured":"Allingham MJ, Mettu PS, Cousins SW. Phase 1 clinical trial of elamipretide in intermediate age-related macular degeneration and high-risk drusen: ReCLAIM high-risk drusen study. Ophthalmology science. 2021;2.","DOI":"10.1016\/j.xops.2021.100095"},{"key":"3341_CR109","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1080\/15548627.2022.2109286","volume":"19","author":"S Datta","year":"2023","unstructured":"Datta S, Cano M, Satyanarayana G, Liu T, Wang L, Wang J, et al. Mitophagy initiates retrograde mitochondrial-nuclear signaling to guide retinal pigment cell heterogeneity. Autophagy 2023;19:966\u201383.","journal-title":"Autophagy"},{"key":"3341_CR110","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41574-021-00626-7","volume":"18","author":"JA Amorim","year":"2022","unstructured":"Amorim JA, Coppotelli G, Rolo AP, Palmeira CM, Ross JM, Sinclair DA. Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nat Rev Endocrinol. 2022;18:243\u201358.","journal-title":"Nat Rev Endocrinol"},{"key":"3341_CR111","doi-asserted-by":"publisher","first-page":"7304","DOI":"10.1523\/JNEUROSCI.0190-15.2015","volume":"35","author":"MR Terluk","year":"2015","unstructured":"Terluk MR, Kapphahn RJ, Soukup LM, Gong H, Gallardo C, Montezuma SR, et al. Investigating mitochondria as a target for treating age-related macular degeneration. J Neurosci. 2015;35:7304\u201311.","journal-title":"J Neurosci"},{"key":"3341_CR112","doi-asserted-by":"crossref","unstructured":"Murray IJ, Rodrigo-Diaz E, Kelly JMF, Aslam TM, Tahir HJ, Carden D, et al. The role of dark adaptation in understanding early AMD. Prog Retin Eye Res. 2022;88.","DOI":"10.1016\/j.preteyeres.2021.101015"},{"key":"3341_CR113","first-page":"1","volume":"13","author":"P Kaynezhad","year":"2023","unstructured":"Kaynezhad P, Tachtsidis I, Sivaprasad S, Jeffery G. Watching the human retina breath in real time and the slowing of mitochondrial respiration with age. Sci Rep. 2023 13:1. 2023;13:1\u20139.","journal-title":"Sci Rep. 2023 13:1"},{"key":"3341_CR114","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41433-020-1110-y","volume":"35","author":"AX Chen","year":"2021","unstructured":"Chen AX, Conti TF, Hom GL, Greenlee TE, Raimondi R, Briskin IN, et al. Functional imaging of mitochondria in retinal diseases using flavoprotein fluorescence. Eye (Lond). 2021;35:74\u201392.","journal-title":"Eye (Lond)"},{"key":"3341_CR115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-023-00388-4","volume":"13","author":"Y Liu","year":"2024","unstructured":"Liu Y, Tan Y, Zhang Z, Yi M, Zhu L, Peng W. The interaction between ageing and Alzheimer\u2019s disease: insights from the hallmarks of ageing. Transl Neurodegeneration. 2024;13:1\u201332.","journal-title":"Transl Neurodegeneration"},{"key":"3341_CR116","doi-asserted-by":"crossref","unstructured":"Jadiya P, Kolmetzky DW, Tomar D, Di Meco A, Lombardi AA, Lambert JP, et al. Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer\u2019s disease. Nat Commun. 2019;10.","DOI":"10.1038\/s41467-019-11813-6"},{"key":"3341_CR117","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3233\/JAD-230072","volume":"93","author":"J Tian","year":"2023","unstructured":"Tian J, Stucky CS, Wang T, Muma NA, Johnson M, Du H. Mitochondrial dysfunction links to impaired hippocampal serotonin release in a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis. 2023;93:605\u201319.","journal-title":"J Alzheimers Dis"},{"key":"3341_CR118","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha EM, De Miranda B, Sanders LH. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurobiol Dis. 2018;109:249\u201357.","journal-title":"Neurobiol Dis"},{"key":"3341_CR119","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.preteyeres.2018.06.002","volume":"67","author":"JB Lin","year":"2018","unstructured":"Lin JB, Apte RS. NAD+ and sirtuins in retinal degenerative diseases: a look at future therapies. Prog Retin Eye Res. 2018;67:118.","journal-title":"Prog Retin Eye Res"},{"key":"3341_CR120","doi-asserted-by":"crossref","unstructured":"Zhang M, Jiang N, Chu Y, Postnikova O, Varghese R, Horvath A, et al. Dysregulated metabolic pathways in age-related macular degeneration. Sci Rep. 2020 Dec 1;10.","DOI":"10.1038\/s41598-020-59244-4"},{"key":"3341_CR121","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.expneurol.2016.11.014","volume":"288","author":"JH Koo","year":"2017","unstructured":"Koo JH, Kang EB, Oh YS, Yang DS, Cho JY. Treadmill exercise decreases amyloid-\u03b2 burden possibly via activation of SIRT-1 signaling in a mouse model of Alzheimer\u2019s disease. Exp Neurol. 2017;288:142\u201352.","journal-title":"Exp Neurol"},{"key":"3341_CR122","doi-asserted-by":"crossref","unstructured":"Singh P, Hanson PS, Morris CM SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson\u2019s disease. BMC Neurosci. 2017;18.","DOI":"10.1186\/s12868-017-0364-1"},{"key":"3341_CR123","doi-asserted-by":"crossref","unstructured":"Ross JM, Coppotelli G, Branca RM, Kim KM, Lehti\u00f6 J, Sinclair DA, et al. Voluntary exercise normalizes the proteomic landscape in muscle and brain and improves the phenotype of progeroid mice. Aging Cell. 2019;18.","DOI":"10.1111\/acel.13029"},{"key":"3341_CR124","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aac4854","volume":"350","author":"E Verdin","year":"2015","unstructured":"Verdin E. NAD+ in aging, metabolism, and neurodegeneration. Science 2015;350:1208\u201313.","journal-title":"Science"},{"key":"3341_CR125","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbi.2017.03.003","volume":"64","author":"X Yang","year":"2017","unstructured":"Yang X, Xu S, Qian Y, Xiao Q. Resveratrol regulates microglia M1\/M2 polarization via PGC-1\u03b1 in conditions of neuroinflammatory injury. Brain Behav Immun. 2017;64:162\u201372.","journal-title":"Brain Behav Immun"},{"key":"3341_CR126","doi-asserted-by":"crossref","unstructured":"Subramani M, Ponnalagu M, Krishna L, Jeyabalan N, Chevour P, Sharma A, et al. Resveratrol reverses the adverse effects of bevacizumab on cultured ARPE-19 cells. Sci Rep. 2017;7.","DOI":"10.1038\/s41598-017-12496-z"},{"key":"3341_CR127","doi-asserted-by":"publisher","first-page":"e113717","DOI":"10.1371\/journal.pone.0113717","volume":"9","author":"DT Vavilala","year":"2014","unstructured":"Vavilala DT, Ponnaluri VKC, Kanjilal D, Mukherji M. Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases. PLoS One. 2014;9:e113717.","journal-title":"PLoS One"},{"key":"3341_CR128","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14:463\u201377.","journal-title":"Nat Rev Immunol"},{"key":"3341_CR129","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature10357","volume":"477","author":"SA Villeda","year":"2011","unstructured":"Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 2011;477:90\u20136.","journal-title":"Nature"},{"key":"3341_CR130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8:1\u201332. 2023 8:1","journal-title":"Signal Transduct Target Ther"},{"key":"3341_CR131","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41433-019-0501-4","volume":"33","author":"L Altay","year":"2019","unstructured":"Altay L, Sitnilska V, Schick T, Widmer G, Duchateau-Nguyen G, Piraino P, et al. Early local activation of complement in aqueous humour of patients with age-related macular degeneration. Eye. 2019;33:1859\u201364. 2019 33:12","journal-title":"Eye"},{"key":"3341_CR132","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/iovs.61.3.18","volume":"61","author":"TJ Heesterbeek","year":"2020","unstructured":"Heesterbeek TJ, Lechanteur YTE, Lor\u00e9s-Motta L, Schick T, Daha MR, Altay L, et al. Complement activation levels are related to disease stage in AMD. Invest Ophthalmol Vis Sci. 2020;61:18\u201318.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3341_CR133","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ophtha.2017.12.023","volume":"125","author":"L Lor\u00e9s-Motta","year":"2018","unstructured":"Lor\u00e9s-Motta L, Paun CC, Corominas J, Pauper M, Geerlings MJ, Altay L, et al. Genome-wide association study reveals variants in CFH and CFHR4 associated with systemic complement activation: implications in age-related macular degeneration. Ophthalmology 2018;125:1064\u201374.","journal-title":"Ophthalmology"},{"key":"3341_CR134","doi-asserted-by":"crossref","unstructured":"Cipriani V, Lor\u00e9s-Motta L, He F, Fathalla D, Tilakaratna V, McHarg S, et al. Increased circulating levels of Factor H-Related Protein 4 are strongly associated with age-related macular degeneration. Nat Commun. 2020;11.","DOI":"10.1038\/s41467-020-14499-3"},{"key":"3341_CR135","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.exer.2019.05.006","volume":"184","author":"R Kumar-Singh","year":"2019","unstructured":"Kumar-Singh R. The role of complement membrane attack complex in dry and wet AMD - From hypothesis to clinical trials. Exp Eye Res. 2019;184:266\u201377.","journal-title":"Exp Eye Res"},{"key":"3341_CR136","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jalz.2019.03.007","volume":"15","author":"AR Morgan","year":"2019","unstructured":"Morgan AR, Touchard S, Leckey C, O\u2019Hagan C, Nevado-Holgado AJ, Barkhof F, et al. Inflammatory biomarkers in Alzheimer\u2019s disease plasma. Alzheimers Dement. 2019;15:776\u201387.","journal-title":"Alzheimers Dement"},{"key":"3341_CR137","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-020-03160-0","volume":"590","author":"PS Minhas","year":"2021","unstructured":"Minhas PS, Latif-Hernandez A, McReynolds MR, Durairaj AS, Wang Q, Rubin A, et al. Restoring metabolism of myeloid cells reverses cognitive decline in ageing. Nature 2021;590:122\u20138.","journal-title":"Nature"},{"key":"3341_CR138","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S. Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol. 2009;8:382\u201397.","journal-title":"Lancet Neurol"},{"key":"3341_CR139","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2013.10","volume":"9","author":"L Parnetti","year":"2013","unstructured":"Parnetti L, Castrioto A, Chiasserini D, Persichetti E, Tambasco N, El-Agnaf O, et al. Cerebrospinal fluid biomarkers in Parkinson disease. Nat Rev Neurol. 2013;9:131\u201340.","journal-title":"Nat Rev Neurol"},{"key":"3341_CR140","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrneurol.2013.132","volume":"9","author":"J Trinh","year":"2013","unstructured":"Trinh J, Farrer M. Advances in the genetics of Parkinson disease. Nat Rev Neurol. 2013;9:445\u201354.","journal-title":"Nat Rev Neurol"},{"key":"3341_CR141","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, et al. In vivo imaging of microglial activation with [11\u2009C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol Dis. 2006;21:404\u201312.","journal-title":"Neurobiol Dis"},{"key":"3341_CR142","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.tips.2022.02.006","volume":"43","author":"WM Zelek","year":"2022","unstructured":"Zelek WM, Morgan BP. Targeting complement in neurodegeneration: challenges, risks, and strategies. Trends Pharm Sci. 2022;43:615\u201328.","journal-title":"Trends Pharm Sci"},{"key":"3341_CR143","doi-asserted-by":"crossref","unstructured":"Tzoumas N, Riding G, Williams MA, Steel DHW Complement inhibitors for age-related macular degeneration. Cochrane Database Syst Rev. 2023;6.","DOI":"10.1002\/14651858.CD009300.pub3"},{"key":"3341_CR144","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s40266-015-0239-z","volume":"32","author":"M Miguel-\u00c1lvarez","year":"2015","unstructured":"Miguel-\u00c1lvarez M, Santos-Lozano A, Sanchis-Gomar F, Fiuza-Luces C, Pareja-Galeano H, Garatachea N, et al. Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer\u2019s disease: a systematic review and meta-analysis of treatment effect. Drugs Aging. 2015;32:139\u201347.","journal-title":"Drugs Aging"},{"key":"3341_CR145","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1471-4159.2010.06595.x","volume":"113","author":"RR Ager","year":"2010","unstructured":"Ager RR, Fonseca MI, Chu SH, Sanderson SD, Taylor SM, Woodruff TM, et al. Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer\u2019s disease. J Neurochem. 2010;113:389\u2013401.","journal-title":"J Neurochem"},{"key":"3341_CR146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2047-9158-2-1","volume":"2","author":"Y Shen","year":"2013","unstructured":"Shen Y, Yang L, Li R. What does complement do in Alzheimer\u2019s disease? Old molecules with new insights. Transl Neurodegeneration. 2013;2:1\u201311. 2013 2:1","journal-title":"Transl Neurodegeneration"},{"key":"3341_CR147","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrd4657","volume":"14","author":"BP Morgan","year":"2015","unstructured":"Morgan BP, Harris CL. Complement, a target for therapy in inflammatory and degenerative diseases. Nat Rev Drug Discov. 2015;14:857\u201377. 2015 14:12","journal-title":"Nat Rev Drug Discov"},{"key":"3341_CR148","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00228-018-2561-y","volume":"75","author":"TN Poly","year":"2019","unstructured":"Poly TN, Islam MMR, Yang HC, Li YCJ. Non-steroidal anti-inflammatory drugs and risk of Parkinson\u2019s disease in the elderly population: a meta-analysis. Eur J Clin Pharm. 2019;75:99\u2013108.","journal-title":"Eur J Clin Pharm"},{"key":"3341_CR149","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.2147\/DDDT.S198753","volume":"13","author":"W Shin","year":"2019","unstructured":"Shin W, Lim KS, Kim MK, Kim HS, Hong J, Jhee S, et al. A first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of KM-819 (FAS-associated factor 1 inhibitor), a drug for Parkinson\u2019s disease, in healthy volunteers. Drug Des Devel Ther. 2019;13:1011\u201322.","journal-title":"Drug Des Devel Ther"},{"key":"3341_CR150","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jnc.13729","volume":"139","author":"L Planells-Ferrer","year":"2016","unstructured":"Planells-Ferrer L, Urresti J, Coccia E, Galenkamp KMO, Calleja-Yag\u00fce I, L\u00f3pez-Soriano J, et al. Fas apoptosis inhibitory molecules: more than death-receptor antagonists in the nervous system. J Neurochem. 2016;139:11\u201321.","journal-title":"J Neurochem"},{"key":"3341_CR151","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.oret.2023.04.014","volume":"7","author":"MJ Hyman","year":"2023","unstructured":"Hyman MJ, Skondra D, Aggarwal N, Moir J, Boucher N, McKay BS. et al.Levodopa is associated with reduced development of neovascular age-related macular degeneration.Opthalmol Retina. 2023;7:745\u201352.","journal-title":"Opthalmol Retina."},{"key":"3341_CR152","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.preteyeres.2018.02.002","volume":"65","author":"MT Pardue","year":"2018","unstructured":"Pardue MT, Allen RS. Neuroprotective strategies for retinal disease. Prog Retin Eye Res. 2018;65:50\u201376.","journal-title":"Prog Retin Eye Res"},{"key":"3341_CR153","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1073\/pnas.1018987108","volume":"108","author":"K Zhang","year":"2011","unstructured":"Zhang K, Hopkins JJ, Heier JS, Birch DG, Halperin LS, Albini TA, et al. Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc Natl Acad Sci USA. 2011;108:6241\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3341_CR154","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/s41591-023-02296-6","volume":"29","author":"YE Tian","year":"2023","unstructured":"Tian YE, Cropley V, Maier AB, Lautenschlager NT, Breakspear M, Zalesky A. Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality. Nat Med. 2023;29:1221\u201331.","journal-title":"Nat Med"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03341-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03341-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03341-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T09:35:31Z","timestamp":1742981731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03341-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":154,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3341"],"URL":"https:\/\/doi.org\/10.1038\/s41433-024-03341-5","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"14 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Stela Vujosevic: Abbvie, Apellis, Bayer, Boehringer & Ingelheim, Novartis, Roche, Zeiss. None relevant to this paper. Celeste Limoli: None. Igor Kozak: pertinent to this review None; otherwise: Roche, Bayer, Abbvie, Alimera, OD-OS.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}